
==== Front
Med Sci (Basel)
Med Sci (Basel)
medsci
Medical Sciences
2076-3271
MDPI

10.3390/medsci12030046
medsci-12-00046
Article
Survival and Durability of Minimally Invasive Mitral Valve Repair: Insights from Different Repair Techniques
Iaccarino Alessandra Conceptualization Investigation Writing – original draft Writing – review & editing 1*
Giambuzzi Ilaria Methodology Software Formal analysis Investigation Writing – original draft Writing – review & editing 1
https://orcid.org/0009-0005-9133-9855
Galbiati Denise Conceptualization Investigation Resources Data curation 1
Cuko Enea Resources 1
Droandi Ginevra Resources 1
Forcina Sara Writing – review & editing 1
Kushta Eraldo Data curation 2
Basciu Alessio Supervision 1
https://orcid.org/0000-0002-5120-5802
Barbone Alessandro Supervision 1
Fumero Andrea Supervision 1
Torracca Lucia Conceptualization Validation Resources Writing – review & editing Visualization Supervision Project administration 1
Torres Antoni Academic Editor
1 Cardiovascular Department, UO of Cardiac Surgery of IRCCS Humanitas Research Hospital, 20089 Rozzano, Italyandrea.fumero@humanitas.it (A.F.);
2 IRCCS Foundation Hospital San Matteo, University of Pavia, 27100 Pavia, Italy; eraldokushta7@gmail.com
* Correspondence: alesandra.iaccarino@humanitas.it
02 9 2024
9 2024
12 3 4608 7 2024
16 8 2024
29 8 2024
© 2024 by the authors.
2024
https://creativecommons.org/licenses/by/4.0/ Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
This study evaluates the long-term outcomes of minimally invasive mitral valve repair (MIMVR) in patients with degenerative mitral regurgitation, focusing on survival, mitral valve repair failure, and re-operation rates. A cohort of patients undergoing three primary repair techniques—quadrangular resection, edge-to-edge repair, and artificial chordae implantation—was analyzed using time-to-event methods. The overall survival rates at 1, 10, and 20 years were high and comparable among the techniques, indicating effective long-term benefits of MIMVR. However, freedom from recurrence of moderate mitral regurgitation (MR) ≥ 2 was significantly higher in the quadrangular resection and edge-to-edge groups compared to the artificial chordae group. No significant differences were observed for recurrent MR ≥ 3. Re-operation rates were low and similar across all techniques, underscoring the durability of MIMVR. Pre-discharge residual MR ≥ 2 was identified as a strong predictor of long-term repair failure. These findings confirm the effectiveness of MIMVR, with all techniques demonstrating excellent long-term survival and durability.

mitral valve repair
mini-thoracotomy mitral valve repair
minimally invasive mitral valve repair
edge-to-edge
quadrangular resection
artificial chordae
This research received no external funding.
==== Body
pmc1. Introduction

Mitral valve regurgitation (MR) is a common valvular heart disease that significantly impacts patient morbidity and mortality. Mitral valve repair (MVP) is the standard of care for patients with degenerative MR. Minimally invasive mitral valve repair (MIMVR) has evolved over the years, and it permits the use of all the various techniques normally employed also through sternotomy [1].

MIMVR has gained popularity due to its potential benefits, such as reduced postoperative pain, shorter hospital stays, and quicker recovery times compared to conventional sternotomy. However, also the choice of surgical technique can influence intra-operative and postoperative outcomes, including cardiopulmonary bypass (CPB) and aortic cross-clamp times, as well as long-term valve function and survival rates. The feasibility of MIMVR in treating degenerative mitral disease has long been recognized. Many centers have incorporated this technique as a standard procedure for patients who do not have anatomical or clinical contraindications. The high success rates of modern mitral repair are largely due to the consistent achievement of long-lasting anatomical and functional valve repairs. Among the various techniques for mitral valve repair, certain methods have proven to be the most reliable and widely used.

The resection technique, an anatomical reconstruction pioneered by Carpentier, has been considered the gold standard since 1983 due to its excellent long-term results [2]. However, this technique has been associated with issues such as impaired left ventricular function, reduced annular area, decreased valve mobility, and increased tissue stress [3].

Tirone David introduced the neo-chordal technique using polytetrafluoroethylene (PTFE) sutures. This method restores the valve and ventricle geometry and movement, provides a large orifice area, maximizes the coaptation line, and reduces tissue stress. It quickly became a viable alternative to resection, also yielding excellent long-term results [4]. The introduction of artificial chordae opened the debate “Resect or Respect”, arguing which technique was better.

Both techniques have limitations in MIMVR: resection is time-consuming, and determining the correct length of neo-chordae is challenging. In parallel, Mohr and von Oppell developed the “Leipzig Loop Technique” to simplify MIMVR by using premeasured chordae [5].

Since posterior mitral leaflet prolapse is the most common and relatively straightforward to repair, studies report excellent long-term outcomes using either the respect or resect technique [6,7]. In contrast, repairing anterior mitral leaflet and bi-leaflet prolapses is more complex and typically yields less favorable results.

In 1991, Ottavio Alfieri introduced the “edge-to-edge” technique for repairing mitral regurgitation in such cases. By applying a suture at the site of the regurgitant jet between the anterior and posterior leaflets (usually A2 and P2), this method creates a “double-orifice” valve, eliminating residual prolapse [8]. This study retrospectively evaluates the pre-operative characteristics, surgical techniques, and peri-operative outcomes of patients who underwent MIMVR. The aim is to characterize the impact of the main techniques (quadrangular resection, edge-to-edge and artificial chordae) on long-term follow-up in terms of mortality and mitral valve repair failure.

2. Materials and Methods

2.1. Study Population

This is a retrospective study focusing on patients who underwent mitral valve repair via mini-thoracotomy between 1999 and 2023, performed by a single experienced surgeon. Only patients diagnosed with degenerative MR were included. The study was conducted in accordance with the declaration of Helsinki, and the local committee (CET Lombardia 5) granted authorization because of the retrospective nature of the study (retrospective study n°35/24).

Only patients undergoing mitral valve repair via mini-thoracotomy were included. Patients younger than 18 years old with secondary mitral regurgitation were excluded.

Mitral valve pathology was confirmed through transthoracic (TTE) and trans-esophageal (TEE) echocardiograms.

Patients were categorized into five groups based on the surgical technique used for mitral valve repair: quadrangular resection, edge-to-edge, artificial chordae, isolated annuloplasty, and a combination of techniques. The main objective was to analyze long-term survival and long-term MVR failure. Mitral valve repair failure included patients with recurrent MR (≥2, ≥3, and REDO surgery on mitral valve).

2.2. Surgical Technique

A small (5–7 cm) right anterolateral mini-thoracotomy was performed in the 3rd or 4th intercostal space. Cardiopulmonary bypass (CPB) was established through femoral arterial and venous cannulation. Endoscopic vision was facilitated using a 30° camera and full HD system. The aorta was cross-clamped either by a Chitwood or Cignet malleable clamp through the thoracotomy, and myocardial protection was achieved via antegrade delivery of cold crystalloid cardioplegia. The left atrium was opened through the interatrial groove, and a left atrial retractor was used to expose the mitral valve (MV). Throughout the surgical procedure, CO2 was actively insufflated into the chest cavity; intra-cardiac air removal was achieved by active ventricular and aortic root suction. Various surgical techniques were employed during the study period, with quadrangular resection, edge-to-edge, and artificial neochordae being the primary ones. A prosthetic ring was always implanted. TEE was routinely performed at the end of CPB to evaluate the presence of residual MR. A comprehensive echocardiographic evaluation was conducted once the patient regained physical autonomy, typically on the 4th postoperative day.

2.3. Follow-Up

Long-term follow-up was completed in 98.58% of cases. Mitral valve function was assessed based on the most recent echocardiographic examination available, either during check-ups at our institution or with the referring cardiologist. Follow-up data were gathered through telephone contact with the patient or family members.

2.4. Statistical Analysis

Data were presented as the mean ± standard deviation or as median and interquartile range (IQR). The Shapiro–Wilk test determined whether the distribution was normal or non-normal. Categorical data were presented as absolute numbers and frequencies and compared using the χ2 test, with the Holm test applied when necessary. Comparison of continuous data (expressed as median and IQR) was performed using the Kruskal–Wallis test, with Bonferroni correction applied as needed. The simple imputation method was applied to missing values. The significance level in hypothesis testing was set to 0.05.

Time-dependent variables as survival and mitral valve failure stratified by type of repair techniques were plotted with Kaplan–Meier curves and compared with the log-rank test. Mitral valve repair failure was defined as recurrent MR ≥ 2+ or MR ≥ 3+ and mitral valve re-intervention. A Cox proportional hazards model was used to identify predictors of mitral failure. The proportional hazards assumption of the Cox model was assessed using the Schoenfeld residual test. Collinearity among variables was checked through the variance inflation factor (VIF) for each predictor variable. In the Cox proportional hazard models, the reference category for mitral techniques was quadrangular resection, for mitral lesion was posterior prolapse, for sex it was male, and for annular prosthetics it was incomplete rings.

In the time-to-event analysis, due to the limited number of patients in the isolated annuloplasty and combination of techniques groups, only patients who underwent quadrangular resection, edge-to-edge, or artificial chordae implantation were included.

Statistical analyses were conducted using R-Studio software (RStudio 2024.04.02).

3. Results

3.1. Pre-Operative Characteristics, Surgical Techniques and Peri-Operative Outcomes

Between December 1999 and December 2023, a total of 538 patients underwent MIMVR. They were divided into 5 groups depending on the type of mitral repair technique they received: quadrangular resection (163 patients, 30.3%), edge-to-edge—either central or paracommisural—(192 patients, 35.69%), artificial neochordae (139 patients, 25.83%), a combination of the three (17 patients, 3.16%), and isolated annuloplasty (27 patients, 5.02%). Pre-operative characteristics are listed in Table 1.

There was a significant difference in age among groups. A Bonferroni correction was applied, and patients who received edge-to-edge were significantly younger than the ones in the other groups, and the patients with artificial chordae were older than patients with resection. Female patients were significantly more common in the edge-to-edge group at the Holm test. Moreover, the lowest EF was in the patients treated with edge-to-edge. Intra-operative and post-operative characteristics are listed in Table 2.

Regarding surgery, only 5 (0.9%) patients were converted to sternotomy because of inappropriate exposure and uncontrollable bleeding. Only 11 (2.05%) patients had a second aortic cross-clamping to review residual MR. CPB time and aortic cross-clamping times were significantly different among groups. At Bonferroni analysis, the significant differences were among patients in the edge-to-edge group when compared to chordae and combination, and also showed a significantly shorter aortic cross-clamping than resection. Artificial chordae group had also longer CPB and aortic cross-clamping times than resection. The patients who received the ring alone did not show any significant difference with any other groups regarding both CPB and aortic cross-clamping time. Patients in the Ring group showed a higher incidence (without reaching statistical significance) of tricuspid valve surgery, which might partially explain the trend of longer surgical times.

The overall rates of post-operative complications were low (Table 2), and no difference was found between groups. No intra-hospital death was recorded. At discharge, 21 (3.9%) patients had a moderate residual MR and 1 patient (0.19%) severe residual MR (who underwent early mitral valve replacement).

3.2. Follow-Up

Median follow-up time was 6.56 years [2.04–9.61] and was 98.58% completed.

At follow-up, there were 5 (1%) deaths (without differences among groups, p-value 0.277). A total of 11 (2.1%) re-operations for mitral valve disease (among groups, p-value 0.219). Recurrent MR ≥ 2 at echocardiogram was found in 44 (8.4%) patients (p-value 0.897), while recurrent MR ≥ 3 was found in 25 (4.8%) patients (p-value 0.158).

In the time-to-event survival analysis, only patients in the resection, edge-to-edge, and chordae were included, as they were the most commonly used procedures. Therefore, a total of 494 patients were included in the analysis. Among the group of patients, there were 4 (0.8%) deaths at follow-up, 39 (7.89%) patients with MR ≥ 2 and 20 (4%) patients with MR ≥ 3, and 9 (1.82%) patients underwent re-intervention. Mean follow-up time in the resection group, edge-to-edge group, and chordae group was, respectively, 7.72 ± 5.60 years, 7.08 ± 5.73 years, and 4.19 ± 3.39 years.

Regarding overall death [Figure 1], there were no differences among the group at log-rank analysis (p-value = 0.52). Freedom from death at 1, 10, and 20 years in the resection group was, respectively, 100% (CI 95% 1–1, reflecting absence of events and censoring), 99% (CI 95% 0.969–1), stable also at 20 years. Regarding the edge-to-edge group, freedom from death at 1, 10, and 20 years was, respectively, 100% (CI 95% 1–1, reflecting absence or events and censoring), 97.8% (CI 95% 0.953–1) stable at 20 years. The chordae group had a lower follow-up time, and survival was 100% up to 10 years.

Regarding recurrent MR ≥ 2 (Figure 2), a significant difference among groups was found (p-value < 0.001). Freedom from MR ≥ 2 at 1, 10, and 20 years in the resection group were, respectively, 98.7% (CI 95% 0.97–1), 93.1% (CI 95% 0.88–0.98), and 75.7% (CI 95% 0.58–0.98). In the edge-to-edge group, freedom from MR ≥ 2 at 1, 10, and 20 years was, respectively, 98.9% (CI 95% 0.97–1), 96.1% (CI 95% 0.93–0.99), and 77.4% (CI 95% 0.64–0.94). In the chordae group, freedom from MR ≥ 2 at 1, 5, and 10 was, respectively, 94.2% (CI 95% 0.89–0.99), 88.8% (CI 95% 0.82–0.96), and 67.1% (CI 95% 0.45–0.99).

A multivariate Cox regression analysis was performed, and results are shown in Table 3. Collinearity was performed, and the VIF values were as follows: Pre-discharge MR ≥ 2 (VIF = 1.005), edge-to-edge (GVIF = 1.003), and artificial chordae (GVIF = 1.003).

Regarding recurrent MR ≥ 3 (Figure 3), no significant difference among groups was found (p-value = 0.063). Freedom from MR ≥ 3 at 1, 10, and 20 years in the resection group was, respectively, 98.7% (CI 95% 0.97–1), 94.4% (CI 95% 0.89–0.99), and 80% (CI 95% 0.63–1). In the edge-to-edge group, freedom from MR ≥ 3 at 1, 10, and 20 years was, respectively, 100% (CI 95% 1–1), 98.6% (CI 95% 0.97–1), and 92.9% (CI 95% 0.85–1). In the chordae group, freedom from MR ≥ 3 at 1, 5, and 10 was, respectively, 100% (CI 95% 1–1), 96.2% (CI 95% 0.91–1), and 75.5% (CI 95% 0.51–1).

A Cox regression univariate analysis was performed, and results are shown in Table 4. Only MR ≥ 2 was a significant predictor.

4. Discussion

The findings of this retrospective study shed light on the outcomes and prognostic factors associated with MIMVR procedures. Our analysis encompasses pre-operative characteristics, surgical techniques, peri-operative outcomes, and long-term follow-up data, providing valuable insights into the management of degenerative MR.

In terms of outcomes, recent studies demonstrate that MIMVR, compared with the conventional sternotomy approach, can be performed without significant differences in mortality and long-term survival [9,10,11,12]. Despite slightly longer CPB and cross-clamp times [13,14], this approach leads to comparable rates of peri-operative mortality, long-term survival, and freedom from re-operation [9,12,15].

The study cohort, comprising 538 patients who underwent MIMVR between 1999 and 2023, was stratified into five groups based on the type of mitral repair technique utilized. Significant variations in age distribution were observed among these groups, with younger patients more commonly undergoing edge-to-edge repair and artificial chordae implantation. Additionally, female patients were more prevalent in the edge-to-edge group.

4.1. Peri-Operative Outcomes

Current literature shows that patients undergoing MIMVR have a similar or even lower incidence of post-operative complications than those of patients undergoing median sternotomy [8,10,11]. A higher rate of stroke after a minimally invasive approach as a consequence of peripheral cannulation or retrograde perfusion might be considered a theoretical disadvantage of this approach [12]. Anyway, some authors disprove these findings given that many studies have shown that there is no significant difference in the incidence of stroke in the two types of surgical approach [7,11,13]. The incidence of stroke in the literature ranges from 0.5% to 2.1% [16]. Specific protocols have been developed to ensure that all patients scheduled for MIMVR undergo a pre-operative CT scan. This is to guarantee safe remote access perfusion and to rule out those who have contraindications for arterial perfusion via the femoral artery. Due to the high standardization of the technique, we can now achieve thorough de-airing through the ascending aorta and CO2 flushing of the right hemithorax. In our series, these results have been confirmed, as the incidence of stroke was very low (0.4%).

Modi et al. reported a systematic meta-analysis of six studies showing similar stroke incidence between minimally invasive and conventional approaches [17]. Longer times of cross-clamp and CPB do not influence early mortality. Conversely, patients treated with a minimally invasive approach less frequently develop renal failure requiring dialysis treatment and show better early survival [9,12,15,18,19,20]. The frequency of bleeding, respiratory failure, and wound infections is comparable to that of the traditional sternotomy approach [9,12,15,18].

Intra-operative and post-operative variables, including conversion to sternotomy, aortic cross-clamping, and cardiopulmonary bypass (CPB) times, were assessed across the different repair techniques. In line with the published literature, edge-to-edge repair demonstrated shorter CPB and aortic cross-clamping times compared to other techniques, highlighting its potential advantages in terms of operative efficiency [21].

Moreover, it is important to underline the low rate of conversion to sternotomy, which was only 0.9%. Many studies examined the influence of MIMVR on the success of mitral valve repair, demonstrating similar or superior repair success rates compared to those of the conventional approach [10,13,16,19]. In our series, residual MR = 2 was present in 14 patients (2.6%), and only in one case (0.2%) the residual MR was severe and required early replacement. Moreover, no intra-hospital death was recorded over a period of 25 years. These results reflect that MIMVR yields the same safety profile as sternotomy, regardless of the type of techniques employed to repair the valve.

4.2. Long-Term Follow-Up and Survival Analysis

The durability of mitral repair is the most crucial predictor of long-term outcomes, influenced by both the repair technique and the location of the primary pathology. Kinza Iqbal et al. [22] conducted a meta-analysis to compare long-term outcomes based on different types of mitral valve lesions, analyzing data from ten articles. This study included 9319 participants, with 2727 undergoing anterior/bilateral mitral valve repair and 6592 undergoing posterior MVP. The follow-up period for assessing long-term outcomes ranged from 5 to 15 years. The study found no significant difference in long-term survival or freedom from moderate-to-severe mitral regurgitation and reoperation between anterior/bi-leaflet and posterior leaflet repairs for mitral valve degenerative disease. The choice and quality of repair significantly impact outcomes, depending largely on the surgeon’s ability to select the appropriate technique for each case.

In the extensive range of retrospective studies that emphasize long-term follow-up, distinctions between standard and MIMVR are often unclear. Conversely, studies on minimally invasive surgery populations tend to focus on shorter-term outcomes [23]. L. Polzl et al. [24] evaluated a consecutive series of patients with Barlow’s disease undergoing minimally invasive MV surgery from 2001 to 2020 (n = 246). Patients were grouped by surgical technique (isolated annuloplasty, use of artificial chordae, or leaflet resection). No significant differences were found between the techniques regarding primary outcomes, including MVARC-event-free survival (mortality, reoperation due to repair failure, or recurrence of severe MR within 5 years). Operative success, defined as primary mitral repair without conversion to valve replacement or major thoracic incisions, no residual MR > mild, and no need for reoperation within the first 30 days, was achieved in 93.5%. Kaplan–Meier estimates showed no significant difference in 5-year mortality or freedom from reoperation among the techniques (log-rank: p-value 0.419 for mortality, 0.205 for reoperation and mortality). MVARC-event-free survival did not differ significantly between groups (2.9% vs. 4.6% vs. 0%; p-value 0.244).

Studies on the long-term outcomes of mitral valve repair have previously been conducted [25,26]. De Bonis et al. [25], for example, reported data on 139 patients undergoing mitral valve repair with the edge-to-edge technique, with a mean follow-up of 11.5 years. At 17 years, survival was 72.4% ± 7.89%, freedom from cardiac death was 90.8% ± 4.77%, freedom from re-operation was 89.6% ± 2.74%, and freedom from MR ≥ 3+ was 80.2% ± 5.86%.

Our median follow-up duration of 6.56 years revealed low mortality rates (1%) and a modest incidence of re-operations for mitral valve disease (2.1%) across our study cohort. The longest follow-up time was 24 years.

Survival analysis demonstrated similar long-term outcomes among the different repair techniques, with no significant differences in overall mortality rates observed. However, significant disparities were noted in freedom from moderate MR (≥2), as artificial chordae had a higher risk of MR ≥ 2 at follow-up. Nevertheless, there was no difference among groups in long-term MR ≥ 3. As expected, the only important predictor that remained significant was pre-discharge moderate MR (≥2) as a strong predictor of adverse outcomes, emphasizing the importance of early post-operative assessment and management.

These results add new insight to the debate on the “resect versus respect” approach. Artificial chordae exhibit a higher rate of recurrent MR ≥ 2 but not for recurrent MR ≥ 3. This observation suggests that technical challenges, such as early and late chordal rupture, incorrect placement, and histopathological phenomena (chordae calcification/no endothelization [27,28]), may play a significant role in MR recurrence. Nevertheless, further studies are needed to clarify if positive remodeling of the left ventricle [29,30] subsequent to mitral valve repair has more impact on artificial chordae [31,32]. Despite being the most respectful technique on the mitral anatomy, the length of the artificial chordae does not adapt as the left ventricle goes back to its original dimensions [33].

Nevertheless, even if the recurrent MR is moderate in patients with artificial chordae, it does not seem to significantly progress towards a meaningful MR.

A recent meta-analysis by Tulio Caldonazo et al. [34] showed that there were no differences between resection and artificial chordae regarding MR recurrence, but the authors do not specify the degree. It is indeed known, and in line with our results, that a pre-discharge MR ≥ 2 is the most important risk factor for recurrence. Nevertheless, in patients with artificial chordae, MR seems to stabilize to a moderate degree during follow-up.

4.3. Study Limitations

The primary limitation of our study is its retrospective design, which means that the results may be affected by factors such as patient selection, the operator’s experience, and the techniques employed over the extensive time period examined. Potential biases related to changes in surgical techniques and the surgeon’s experience over time cannot be ruled out. Additionally, comprehensive echocardiographic data collection during follow-up was hindered because these exams were only partially performed at our institution, with many patients being followed up at external centers. Moreover, limited data on left ventricle function and dimensions, or valve failure mechanisms, were available at follow-up.

5. Conclusions

This study provides valuable insights into the outcomes of MIMVR (MIMVR) for patients with degenerative MR, focusing on long-term survival and mitral valve repair failure. The study confirms that MIMVR is a viable and effective option for treating degenerative MR, despite the chosen technique of repair, with excellent long-term survival and low rates of repair failure and re-operation.

Author Contributions

Conceptualization, L.T., A.I., A.B. (Alessandro Barbone) and D.G.; methodology, I.G.; software, I.G.; validation, L.T.; formal analysis, I.G.; investigation, I.G.; resources, L.T., D.G., E.C. and G.D.; data curation, D.G. and E.K.; writing—original draft preparation, I.G. and A.I.; writing—review and editing, I.G., A.I., L.T. and S.F.; visualization, L.T.; supervision, L.T., A.F., A.B. (Alessio Basciu) and A.B. (Alessandro Barbone); project administration, L.T. All authors have read and agreed to the published version of the manuscript.

Institutional Review Board Statement

The study was conducted in accordance with the declaration of Helsinki, and approved by the Ethics Committee (CET Lombardia 5) of IRCCS Humanitas Research Hospital (retrospective study n°35/24—date of approval 23 July 2024).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Raw data are available upon request to the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.

Figure 1 KM of overall death.

Figure 2 KM of recurrent MR ≥ 2.

Figure 3 KM of recurrent MR ≥ 3.

medsci-12-00046-t001_Table 1 Table 1 Pre-operative characteristics.

Variable	Overall	Resection	Edge-To-Edge	Chordae	Ring	Combination	p-Value	
TOTAL	538	163	192	139	27	17		
FEMALE	188 (34.9)	41 (25.2)	94 (49.0)	34 (24.5)	14 (51.9)	5 (29.4)	<0.001	
AGE (yrs)	48.39 ± 12.42	49.53 ± 10.85	42.43 ± 12.93	53.76 ± 9.93	51.87 ± 14.7	53.60 ± 7.79	<0.001	
NYHA > 3	69 (12.8)	29 (17.8)	25 (13.0)	10 (7.2)	3 (11.1)	2 (11.8)	0.106	
NYHA							0.149	
1	272 (50.6)	65 (39.9)	104 (54.2)	80 (57.6)	12 (44.4)	11 (64.7)		
2	197 (36.6)	69 (42.3)	63 (32.8)	49 (35.3)	12 (44.4)	4 (23.5)		
3	67 (12.5)	28 (17.2)	24 (12.5)	10 (7.2)	3 (11.1)	2 (11.8)		
4	2 (0.4)	1 (0.6)	1 (0.5)	0 (0.0)	0 (0.0)	0 (0.0)		
REDO	1 (0.2)	0 (0.0)	1 (0.5)	0 (0.0)	0 (0.0)	0 (0.0)	0.771	
EF (%)	63 [60–68]	65 [60–69]	60 [58–65]	64 [60–68]	62 [57.5–64]	62.5 [60–68.5]	0.02	
RHYTHM							0.066	
SR	495 (92.0)	150 (92.0)	172 (89.6)	136 (97.8)	23 (85.2)	14 (82.4)		
AF	41 (7.6)	13 (8.0)	19 (9.9)	2 (1.4)	4 (14.8)	3 (17.6)		
PM	2 (0.4)	0	1(0.5)	1 (0.7)	0	0		
PROLAPSE								
PL	333 (61.9)	162 (99.4)	22 (11.5)	125 (89.9)	13 (48.1)	11 (64.7)	<0.001	
AL	52 (9.7)	0 (0.0)	36 (18.8)	8 (5.8)	5 (18.5)	3 (17.6)	<0.001	
BL	157 (29.2)	1 (0.6)	134 (69.8)	10 (7.2)	5 (18.5)	7 (41.2)	<0.001	
REDO: re-intervention, EF: ejection fraction; SR: sinus rhythm; AF: atrial fibrillation; PM: pacemaker; PL: posterior leaflet; AL: anterior leaflet; BL: bi-leaflet. Continuous variables are presented as “median [IQR]” or “mean ± SD”, categorical variables are presented as absolute values and percentages n (%).

medsci-12-00046-t002_Table 2 Table 2 Intra-operative and post-operative characteristics.

Variable	Overall	Resection	Edgetoedge	Chordae	Ring	Combination	p-Value	
	538	163	192	139	27	17		
Intra-Operative Data	
CPB time (min)	117 [95.2–143]	104 [90–124]	104 [84–129]	134 [116–156]	120 [95–151]	159 [126–194]	<0.001	
Cross-clamping time (min)	85 [70–107]	81 [69–98.8]	74 [62–93]	100 [83–116]	93 [68–117]	116 [91.2–142]	<0.001	
Tricuspid valve surgery	125 (23.2)	32 (19.6)	40 (20.8)	39 (28.1)	9 (33.3)	5 (29.4)	0.237	
Post-Operative Complication	
PM implant	2 (0.4)	0	2 (1)	0	0	0	0.460	
IABP	23 (4.3)	2 (1.2)	8 (4.2)	10 (7.2)	1 (3.7)	2 (11.8)	0.062	
Transfusion	72 (13.4)	18 (11)	26(13.5)	18(12.9)	4 (14.8)	6 (35.3)	0.069	
Respiratory failure	7 (1.3)	2 (1.2)	3 (1.6)	1 (0.7)	0	1 (5.9)	0.461	
Surgical revision	7 (1.3)	0	3 (1.6)	2 (1.4)	2 (7.4)	0	0.035	
AF	88 (16.4)	22 (13.5)	32 (16.7)	24 (17.3)	6 (22.2)	4 (23.5)	0.664	
AMI	5 (0.9)	2 (1.2)	2 (1)	1 (0.7)	0	0	0.956	
STROKE	2 (0.4)	0	1 (0.5)	0	0	1 (5.9)	0.004	
Intra-hospital mortality	0	0	0	0	0	0	0	
Surgical wound problems	6 (1.1)	1 (0.6)	3 (1.6)	2 (1.4)	0	0	0.853	
Pericardial effusion	11 (2)	2 (1.2)	5 (2.6)	3 (2.2)	1 (3.7)	0	0.813	
Post-op MR							0.362	
0	413 (76.8)	120 (73.6)	153 (79.7)	105 (75.5)	20 (74.1)	15 (88.2)		
1	110 (20.4)	37 (22.7)	32 (16.7)	34 (24.5)	6 (22.2)	1 (5.9)		
2	14 (2.6)	5 (3.1)	7 (3.6)	0 (0.0)	1 (3.7)	1 (5.9)		
3	0	0	0	0	0	0		
4	1 (0.2)	1 (0.6)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)		
Post-op MR ≥ 2	15 (2.8)	7 (4.3)	9 (4.7)	4 (2.9)	1 (3.7)	1 (5.9)	0.930	
AF: atrial fibrillation, PM: pacemaker, MR: mitral regurgitation, AMI: acute myocardial infarction, Surgical Revision: revision for bleeding.

medsci-12-00046-t003_Table 3 Table 3 Cox regression analysis for MR ≥ 2.

Variable	Univariate	Multivariate	
	HR	CI	p-Value	HR	CI	p-Value	
Pre-discharge MR ≥ 2	7.25	3.523–14.922	<0.001	10.17	4.52–22.86	<0.001	
AL	1.08	0.4256–2.7554	0.866				
BL	0.51	0.2446–1.1011	0.08				
Sex	1.06	0.4877–2.3229	0.856				
NYHA > 2	1.16	0.6888–1.9513	0.724				
TVR	1.322	0.6026–2.9012	0.486				
EtE	0.73	0.329–1.611	0.433	0.90	0.4073–2.01	0.803	
ArtCh	4.02	1.647–9.854	0.002	6.28	2.39–16.48	<0.001	
AL: anterior leaflet, BL: bi-leaflet, EtE: edge-to-edge, TVR: tricuspid valve repair, ArtCh: artificial chordae.

medsci-12-00046-t004_Table 4 Table 4 Cox regression analysis for MR ≥ 3.

Variable	Univariate	
HR	CI	p–Value	
Pre-discharge MR ≥ 2	11.33	4.38–29.34	<0.01	
AL	0.658	0.14–3.09	0.569	
BL	0.604	−0.22–1.63	0.317	
Sex	1.49	0.60–3.70	0.391	
NYHA > 2	0.91	0.27–3.16	0.89	
TVR	1.79	0.640–5.028	0.264	
EtE	0.4349	0.156–1.212	0.111	
ArtCh	2.04	−0.586–2.017	0.280	
AL: anterior leaflet, BL: bi-leaflet, EtE: edge-to-edge, TVR: tricuspid valve repair, ArtCh: artificial chordae.

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
==== Refs
References

1. Sá M.P. Jacquemyn X. Erten O. Van den Eynde J. Caldonazo T. Doenst T. Ruhparwar A. Weymann A. de Souza R.O.R.R. Rodriguez R. Long-Term Outcomes of Sternal-Sparing Versus Sternotomy Approaches for Mitral Valve Repair: Meta-Analysis of Reconstructed Time-to-Event Data Innovations 2023 18 167 174 10.1177/15569845231166902 37129060
2. Carpentier A. Cardiac Valve Surgery—The “French Correction” J. Thorac. Cardiovasc. Surg. 1983 86 323 337 10.1016/S0022-5223(19)39144-5 6887954
3. Mazine A. Friedrich J.O. Nedadur R. Verma S. Ouzounian M. Jüni P. Puskas J.D. Yanagawa B. Systematic Review and Meta-Analysis of Chordal Replacement versus Leaflet Resection for Posterior Mitral Leaflet Prolapse J. Thorac. Cardiovasc. Surg. 2018 155 120 128.e10 10.1016/j.jtcvs.2017.07.078 28967416
4. David T.E. Replacement of Chordae Tendineae with Expanded Polytetrafluoroethylene Sutures J. Card. Surg. 1989 4 286 290 10.1111/j.1540-8191.1989.tb00291.x 2520006
5. von Oppell U.O. Mohr F.W. Chordal Replacement for Both Minimally Invasive and Conventional Mitral Valve Surgery Using Premeasured Gore-Tex Loops Ann. Thorac. Surg. 2000 70 2166 2168 10.1016/S0003-4975(00)02047-6 11156150
6. Mohty D. Orszulak T.A. Schaff H.V. Avierinos J.F. Tajik J.A. Enriquez-Sarano M. Very Long-Term Survival and Durability of Mitral Valve Repair for Mitral Valve Prolapse Circulation 2001 104 I1 I7 10.1161/hc37t1.094903 11568020
7. Ma J. Liu J. Wei P. Yao X. Zhang Y. Fang L. Chen Z. Liu Y. Tan T. Wu H. Quadrangular Resection versus Chordal Replacement for Degenerative Posterior Mitral Leaflet Prolapse Ann. Transl. Med. 2021 9 60 10.21037/atm-20-7475 33553353
8. Belluschi I. Buzzatti N. Castiglioni A. Alfieri O. De Bonis M. The Alfieri’s Edge-to-Edge Technique for Mitral Valve Repair: From a Historical Milestone of Cardiac Surgery to the Origin of the Transcatheter Era Mini-Invasive Surg. 2020 4 58 10.20517/2574-1225.2020.48
9. Goldstone A.B. Atluri P. Szeto W.Y. Trubelja A. Howard J.L. MacArthur J.W. Jr. Newcomb C. Donnelly J.P. Kobrin D.M. Sheridan M.A. Minimally Invasive Approach Provides at Least Equivalent Results for Surgical Correction of Mitral Regurgitation: A Propensity-Matched Comparison J. Thorac. Cardiovasc. Surg. 2013 145 748 756 10.1016/j.jtcvs.2012.09.093 23414991
10. Cheng D.C.H. Martin J. Lal A. Diegeler A. Folliguet T.A. Nifong L.W. Perier P. Raanani E. Smith J.M. Seeburger J. Minimally Invasive versus Conventional Open Mitral Valve Surgery: A Meta-Analysis and Systematic Review Innovations 2011 6 84 103 10.1097/IMI.0b013e3182167feb 22437892
11. Moscarelli M. Casula R. Speziale G. Athanasiou T. Can We Use Minimally Invasive Mitral Valve Surgery as a Safe Alternative to Sternotomy in High-Risk Patients? Interact. Cardiovasc. Thorac. Surg. 2016 22 92 96 10.1093/icvts/ivv275 26451001
12. Sündermann S.H. Czerny M. Falk V. Open vs. Minimally Invasive Mitral Valve Surgery: Surgical Technique, Indications and Results Cardiovasc. Eng. Technol. 2015 6 160 166 10.1007/s13239-015-0210-5 26577232
13. Moscarelli M. Fattouch K. Gaudino M. Nasso G. Paparella D. Punjabi P. Athanasiou T. Benedetto U. Angelini G.D. Santarpino G. Minimal Access Versus Sternotomy for Complex Mitral Valve Repair: A Meta-Analysis Ann. Thorac. Surg. 2020 109 737 744 10.1016/j.athoracsur.2019.07.034 31479637
14. Jiang Q. Wang Z. Guo J. Yu T. Zhang X. Hu S. Retrospective Comparison of Endoscopic Versus Open Procedure for Mitral Valve Disease J. Investig. Surg. 2021 34 1000 1006 10.1080/08941939.2020.1726531 32064986
15. Atluri P. Stetson R.L. Hung G. Gaffey A.C. Szeto W.Y. Acker M.A. Hargrove W.C. Minimally Invasive Mitral Valve Surgery Is Associated with Equivalent Cost and Shorter Hospital Stay When Compared with Traditional Sternotomy J. Thorac. Cardiovasc. Surg. 2016 151 385 388 10.1016/j.jtcvs.2015.08.106 26432722
16. Murzi M. Cerillo A.G. Miceli A. Bevilacqua S. Kallushi E. Farneti P. Solinas M. Glauber M. Antegrade and Retrograde Arterial Perfusion Strategy in Minimally Invasive Mitral-Valve Surgery: A Propensity Score Analysis on 1280 Patients Eur. J. Cardiothorac. Surg. 2013 43 e167 e172 10.1093/ejcts/ezt043 23404687
17. Modi P. Hassan A. Chitwood W.R. Jr. Minimally Invasive Mitral Valve Surgery: A Systematic Review and Meta-Analysis Eur. J. Cardiothorac. Surg. 2008 34 943 952 10.1016/j.ejcts.2008.07.057 18829343
18. Downs E.A. Johnston L.E. LaPar D.J. Ghanta R.K. Kron I.L. Speir A.M. Fonner C.E. Kern J.A. Ailawadi G. Minimally Invasive Mitral Valve Surgery Provides Excellent Outcomes without Increased Cost: A Multi-Institutional Analysis Ann. Thorac. Surg. 2016 102 14 21 10.1016/j.athoracsur.2016.01.084 27041453
19. Duran C.M. Surgical Techniques for the Repair of Anterior Mitral Leaflet Prolapse J. Card. Surg. 1999 14 471 481 10.1111/j.1540-8191.1999.tb01281.x 11021375
20. Bedeir K. Reardon M. Ramchandani M. Singh K. Ramlawi B. Elevated Stroke Risk Associated with Femoral Artery Cannulation During Mitral Valve Surgery Semin. Thorac. Cardiovasc. Surg. 2015 27 97 103 10.1053/j.semtcvs.2015.06.008 26686431
21. Belluschi I. Lapenna E. Blasio A. Del Forno B. Giacomini A. Ruggeri S. Schiavi D. Castiglioni A. Alfieri O. De Bonis M. Excellent Long-Term Results with Minimally Invasive Edge-to-Edge Repair in Myxomatous Degenerative Mitral Valve Regurgitation Interact. Cardiovasc. Thorac. Surg. 2020 31 28 34 10.1093/icvts/ivaa048 32221590
22. Iqbal K. Haque I.U. Shaikh V.F. Rathore S.S. Yasmin F. Iqbal A. Shariff M. Kumar A. Stulak J.M. Mitral Valve Repair for Anterior/Bi-Leaflet Versus Posterior Leaflet Degenerative Mitral Valve Disease: A Systematic Review and Meta-Analysis Curr. Probl. Cardiol. 2022 47 101355 10.1016/j.cpcardiol.2022.101355 35970298
23. Bonaros N. Hoefer D. Oezpeker C. Gollmann-Tepeköylü C. Holfeld J. Dumfarth J. Kilo J. Ruttmann-Ulmer E. Hangler H. Grimm M. Predictors of Safety and Success in Minimally Invasive Surgery for Degenerative Mitral Disease Eur. J. Cardiothorac. Surg. 2022 61 637 644 10.1093/ejcts/ezab438 34738105
24. Pölzl L. Gollmann-Tepeköylü C. Nägele F. Cetin K. Spilka J. Holfeld J. Oezpeker U.C. Stastny L. Graber M. Hirsch J. Five-Year Outcomes of Different Techniques for Minimally Invasive Mitral Valve Repair in Barlow’s Disease Eur. J. Cardiothorac. Surg. 2024 65 ezae213 10.1093/ejcts/ezae213 38781502
25. De Bonis M. Lapenna E. Taramasso M. La Canna G. Buzzatti N. Pappalardo F. Alfieri O. Very Long-Term Durability of the Edge-to-Edge Repair for Isolated Anterior Mitral Leaflet Prolapse: Up to 21 Years of Clinical and Echocardiographic Results J. Thorac. Cardiovasc. Surg. 2014 148 2027 2032 10.1016/j.jtcvs.2014.03.041 24755329
26. De Bonis M. Lapenna E. Maisano F. Barili F. La Canna G. Buzzatti N. Pappalardo F. Calabrese M. Nisi T. Alfieri O. Long-Term Results (≤18 Years) of the Edge-to-Edge Mitral Valve Repair without Annuloplasty in Degenerative Mitral Regurgitation: Implications for the Percutaneous Approach Circulation 2014 130 S19 S24 10.1161/CIRCULATIONAHA.113.007885 25200050
27. Vendramin I. Milano A.D. Pucci A. Lechiancole A. Sponga S. Bortolotti U. Livi U. Artificial Chordae for Mitral Valve Repair J. Card. Surg. 2022 37 3722 3728 10.1111/jocs.16937 36116053
28. Luthra S. Eissa A. Malvindi P.G. Tsang G.M. Calcification of Gore-Tex Neochord After Mitral Repair: Electron Microscopy Ann. Thorac. Surg. 2022 114 e1 e3 10.1016/j.athoracsur.2021.08.057 34599910
29. Shafii A.E. Gillinov A.M. Mihaljevic T. Stewart W. Batizy L.H. Blackstone E.H. Changes in Left Ventricular Morphology and Function after Mitral Valve Surgery Am. J. Cardiol. 2012 110 403 408.e3 10.1016/j.amjcard.2012.03.041 22534055
30. Hayata Y. Sawabata N. Abe T. Hirose T. Yamashita K. Hiraga S. Fukuba R. Takemura J. Nakano T. Saito Y. Improvement in Left Cardiac Function Following Mitral Valve Repair: Analyses Based on Cardiac Magnetic Resonance Imaging In Vivo 2020 34 2897 2903 10.21873/invivo.12118 32871830
31. Di Mauro M. Bonalumi G. Giambuzzi I. Messi P. Cargoni M. Paparella D. Lorusso R. Calafiore A.M. Mitral Valve Repair with Artificial Chords: Tips and Tricks J. Card. Surg. 2022 37 4081 4087 10.1111/jocs.17076 36321669
32. Moore R.A. Wierup P. Burns D.J.P. Gillinov A.M. Early Failure after Non-Resectional Mitral Valve Repair with Artificial Chordae J. Card. Surg. 2020 35 2432 2435 10.1111/jocs.14817 32725653
33. Hibino M. Dhingra N.K. Chan V. Mazer C.D. Teoh H. Quan A. Verma R. Leong-Poi H. Bisleri G. Connelly K.A. Stage-Based Approach to Predict Left Ventricular Reverse Remodeling after Mitral Repair Clin. Cardiol. 2022 45 921 927 10.1002/clc.23879 35748086
34. Caldonazo T. Sá M.P. Jacquemyn X. Van den Eynde J. Kirov H. Harik L. Fischer J. Vervoort D. Bonatti J. Sultan I. Respect Versus Resect Approaches for Mitral Valve Repair: A Meta-Analysis of Reconstructed Time-to-Event Data Am. J. Cardiol. 2024 213 5 11 10.1016/j.amjcard.2023.12.010 38104750
